Craig Landau told The Washington Post that Purdue is developing a powerful anti-overdose drug in a pro-bono effort to combat the effects of the opioid crisis.
The headquarters of Purdue Pharma, the drugmaker that produces OxyContin, is seen March 5 in Stamford, Conn. By Katie Zezima Katie Zezima National reporter covering vice Email Bio Follow March 13 at 9:01 AM Purdue Pharma’s chief executive said the company is considering bankruptcy as it faces a cascade of lawsuits alleging that the drugmaker played a key role in driving the nation’s opioid crisis, including aggressively and deceptively marketing the powerful painkiller OxyContin.
Purdue is one of a number of defendants in a separate Oklahoma state trial scheduled to begin May 28. It will be the first trial at which a jury could decide whether drug companies bear responsibility for the opioid crisis; settlement talks are ongoing. People familiar with the case have said Oklahoma could seek more than $1 billion from the defendants.
The company said that the Food and Drug Administration has granted the drug — an injection of nalmefene hydrochloride — the agency’s fast-track designation, which will speed up its pharmaceutical development and agency review. The FDA fast-tracked over-the-counter naloxone in January, and it is moving quickly on non-opioid drugs to treat pain.
Fentanyl is the third wave of the opioid epidemic, which started with prescription painkillers. After the government cracked down on illicit prescribers and tried to address the flow of pills to the black market, those addicted to the painkillers turned to heroin.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trialOxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid t...
Read more »
Prison authorities say they are investigating 'pharma bro' ShkreliThe U.S. Bureau of Prisons said on Friday it was investigating former drug compa...
Read more »
Feds probe alleged prison cellphone use by 'Pharma Bro'Federal authorities said Friday they are investigating claims that Martin Shkreli has been running his pharmaceutical company from behind bars using a contraband smartphone. The U.S. Bureau of Prisons told The Associated Press it has opened an inquiry into whether the man nicknamed the 'Pharma
Read more »
Officials investigating 'Pharma Bro' Martin Shkreli's alleged cellphone use from prisonA recent report alleged that the former drug company executive was helping run his firm using a contraband cellphone.
Read more »
Historic trial against Big Pharma will start in May, judge saysAn Oklahoma judge ruled Friday that a historic opioid trial against several major pharmaceutical companies will begin May 28, rejecting their motion to delay the trial.
Read more »
Hedge Fund Tosses Family That Controls Maker of OxyContinThe billionaire family that controls OxyContin maker Purdue Pharma, already facing mounting legal and financial pressure, has been tossed out of a large hedge fund for its alleged role in fueling the opioid crisis.
Read more »
Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 yearsWelcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Read more »
Former pharma exec Martin Shkreli being probed by the feds over accusations he's running his business from prisonA recent Wall Street Journal report claims he used a cellphone (not allowed in prison) to post to social media and even fire an executive.
Read more »